MEDTRONIC PUERTO RICO OPERATIONS CO. INTELLIS; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR
|
Back to Search Results |
|
Model Number 97715 |
Device Problems
Migration or Expulsion of Device (1395); Unintended Collision (1429); Patient Device Interaction Problem (4001)
|
Patient Problem
Insufficient Information (4580)
|
Event Date 10/01/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 977a260, serial#: (b)(4), implanted: (b)(6) 2020, product type: lead.Product id: 977a260, serial#: (b)(4), implanted: (b)(6) 2020, product type: lead.Other relevant device(s) are: product id: 977a260, serial/lot #: (b)(4), ubd: 16-jul-2023, udi#: (b)(4); product id: 977a260, serial/lot #: (b)(4), ubd: 16-jul-2023, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient via manufacturer representative who was implanted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that the patient's trial went very well and he was super happy and pleased.But since the implant he said it has never worked.He is not getting the back pain relief he got during the trial. patient told the rep he played golf shortly after implant.The patient said it was about 6 weeks after and he told another rep he played golf about 3-4 weeks after the implant.He was also in a bad car accident about 2 weeks ago. x-ray taken today showed both leads have moved down 1-1.5 vertebral levels.During the trial & at the time of implant leads were at the top of t8 and now they are at the top of t9.The rep tried reprogramming today and he is going to try the 2 new programs over the next few days.If that doesn't work the doctor is planning on referring him for a lead revision and possibly a paddle lead.Surgical intervention has been planned, but not scheduled.
|
|
Manufacturer Narrative
|
Continuation of d10: product id: 977a260, serial# (b)(6), implanted: (b)(6) 2020, explanted: (b)(6) 2022, product type: lead.Product id: 977a260, serial# (b)(6), implanted: (b)(6) 2020, product type: lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Rep reported issue resolved.Turned on scs today and patient feeling in his low back and buttock.See (b)(4) for omitted details regarding the ins getting repositioned and shocking the pt.
|
|
Manufacturer Narrative
|
G4: the correct date is 2022-06-21 for follow up number 002.¿ medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Continuation of d10: product id 977a260, serial# (b)(6), implanted: (b)(6) 2020, explanted: (b)(6) 2022, product type lead product id 977a260, serial# (b)(6), implanted: (b)(6) 2020, explanted: product type lead.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from a patient (pt) who was implanted with an implantable neurostimulator (ins).The pt reported the lead was explanted and a new lead was implanted on (b)(6).
|
|
Search Alerts/Recalls
|
|
|